High Risk Lung Cancer Screening Program Saves Lives
Of the top four deadliest cancers in the US (lung, prostate, breast and colorectal) lung cancer is the only one not subject to routine screening.
On February 10, 2022 the Centers for Medicare & Medicaid Services (CMS) announced a national coverage determination (NCD) that expands coverage for lung cancer screening with low dose computed tomography (LDCT) to improve health outcomes for people with lung cancer.
Come learn the new guidelines as well as local resources for your patients.
Discussion
By posting you agree to the Terms and Privacy Policy.